Gemcitabine and bendamustine is a safe and effective salvage regimen for patients with recurrent/refractory Hodgkin lymphoma: Results of a phase 1/2 study

Jonathon B. Cohen, Lai Wei, Kami J. Maddocks, Beth Christian, Leonard T. Heffner, Amelia A. Langston, Mary Jo Lechowicz, Pierluigi Porcu, Christopher R. Flowers, Steven M. Devine, Kristie A. Blum

Research output: Contribution to journal › Article › peer-review

8 Scopus citations

Fingerprint

Dive into the research topics of 'Gemcitabine and bendamustine is a safe and effective salvage regimen for patients with recurrent/refractory Hodgkin lymphoma: Results of a phase 1/2 study'. Together they form a unique fingerprint.

Medicine & Life Sciences